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Abstract
Mitochondria are strategically localized at sites of Ca2 release, such that increases in cytosolic free Ca2 ([Ca2]c) from
either internal Ca2 stores or Ca2 influx across the plasma membrane can be rapidly transported into the mitochondrial
matrix. The consequent elevation in mitochondrial Ca2 ([Ca2]m) stimulates the Ca2-sensitive intramitochondrial
dehydrogenases, resulting in elevation of NAD(P)H. The preferential coupling between increases in [Ca2]c and [Ca2]m is
one proposed mechanism to coordinate mitochondrial ATP production with cellular energy demand. In liver cells, hormones
that act through the second messenger inositol 1,4,5-trisphosphate (IP3) generate oscillatory [Ca2]c signals, which result
from a periodic Ca2- and IP3-mediated activation/deactivation of intracellular Ca2 release channels. The [Ca2]c spiking
frequency increases with agonist dose, whereas the amplitude of each [Ca2]c spike is constant. This frequency modulation of
[Ca2]c spiking encodes the signal from the extracellular agonist, which is then decoded by the internal Ca2-sensitive
proteins such as the Ca2-sensitive intramitochondrial dehydrogenases. Our studies have investigated the relationship
between IP3-dependent [Ca2]c signals and [Ca2]m in primary cultured hepatocytes. In addition, the changes in cellular
[Ca2] levels have been correlated with the regulation of intramitochondrial NAD(P)H levels, pyruvate dehydrogenase
activity and the magnitude of the mitochondrial proton motive force. ß 1998 Elsevier Science B.V. All rights reserved.
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chondrial proton motive force; Pyruvate dehydrogenase
1. Introduction
Periodic £uctuations in the cytosolic calcium con-
centration ([Ca2]c) is a common feature in both ex-
citable and non-excitable cells, which may be driven
by electrical activation or by stimulation with hor-
mones coupled to Ca2-mobilizing second messen-
gers such as inositol 1,4,5-trisphosphate (IP3). In
many tissues, including the heart and liver, elevating
[Ca2]c stimulates contractile, secretory or metabolic
pathways leading to increased ATP demand in the
cytosol. In order to maintain cellular energy homeo-
stasis, living cells need to balance the rate of ATP
utilization with ATP synthesis. This requires that the
cell e⁄ciently coordinate the £ux rate through cyto-
solic ATP-driven reactions with the activation of mi-
0005-2728 / 98 / $19.00 ß 1998 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 2 8 ( 9 8 ) 0 0 1 1 8 - 2
* Corresponding author. Fax: +1 (973) 972 7950;
E-mail : thomasap@umdnj.edu
BBABIO 44662 28-7-98 Cyaan Magenta Geel Zwart
Biochimica et Biophysica Acta 1366 (1998) 17^32
tochondrial oxidative phosphorylation. While mech-
anisms which control the rate of oxidative phospho-
rylation are not clearly de¢ned in the intact cell,
there are several regulatory mechanisms proposed
to control mitochondrial respiratory activity and
hence ATP production. These include the end prod-
ucts of ATP hydrolysis (cytosolic concentrations of
ADP and inorganic phosphate), supply of reducing
equivalents to the mitochondrial respiratory chain,
nonphosphorylative proton-cycling reactions (i.e.
proton leak) (reviewed in [1^5]) and possibly blood
£ow regulating tissue oxygen delivery [1].
In isolated mitochondria the control of oxidative
phosphorylation is distributed among several reac-
tions in the pathway, with the degree of control ex-
erted by each site dependent upon the metabolic con-
ditions (reviewed in [1,3,5]). Control of respiration
and ATP production in mitochondria in situ is also
regulated by multiple pathways. For example, it has
been estimated by Brand and coworkers [6] that 50%
of the control over basal respiration resides in the
phosphorylation pathways including cytoplasmic
ATP hydrolysis, adenine nucleotide transport and
ATP synthesis. An additional 30% is controlled by
processes upstream of mitochondrial NADH such as
glycolysis, pyruvate dehydrogenase and Krebs cycle
dehydrogenases, while the remaining control over
basal respiration was assigned to processes that dis-
sipate the proton motive force via nonphosphoryla-
tive pathways. During increased cellular ATP de-
mand, mitochondrial ATP production could be
enhanced through changes in any one of these con-
trol sites [3]. In addition, hormonal signaling path-
ways may directly control £ux through the respira-
tory chain and these e¡ects of hormone pretreatment
can persist in subsequently isolated mitochondria [7^
10].
Although the cytosolic phosphorylation potential
is clearly a major regulator of mitochondrial ATP
production, there are additional mechanisms that
function to enhance mitochondrial energy metabo-
lism in parallel with increased energy demand. One
example of coordinated control between cytosolic
and mitochondrial activity is achieved through in-
creases in [Ca2]c, which may result from hormone
action on intracellular Ca2 stores in non-excitable
cells. It has been proposed that the increase in
[Ca2]c leads to elevations in mitochondrial Ca2
([Ca2]m), and subsequent activation of Ca2-sensi-
tive intramitochondrial dehydrogenases, providing
increased respiratory substrates for the electron
transport system [4,11]. The intramitochondrial de-
hydrogenases sensitive to elevations in [Ca2]m are
the pyruvate dehydrogenase (PDH), 2-oxoglutarate
dehydrogenase (OGDH), and NAD-isocitrate dehy-
drogenase (NAD-ICDH). The e¡ects of Ca2 on
PDH is mediated through a Ca2-sensitive phospha-
tase leading to dephosphorylation and activation
of the enzyme [12,13], whereas Ca2 directly inter-
acts with OGDH and NAD-ICDH to decrease the
Km for their respective substrates [14^16]. Our work
has focused on how IP3-dependent [Ca2]c oscilla-
tions are transferred into the mitochondrial matrix
in intact hepatocytes and how the [Ca2]c oscilla-
tions are decoded to yield a ¢nal metabolic output
re£ected in the levels of NAD(P)H and pyruvate
dehydrogenase activity. In addition, we have inves-
tigated whether [Ca2]c elevation has a direct e¡ect
on mitochondrial proton motive force in the hepato-
cyte.
2. IP3-dependent [Ca2+]c signaling
A common mechanism used by extracellular stim-
uli to exert control over cellular metabolism relies on
mobilization of Ca2 from intracellular stores and
entry of Ca2 from the extracellular medium, result-
ing in an increase in [Ca2]c. In non-excitable tissues,
such as the liver, activation of plasma membrane
receptors coupled to the phosphoinositide signaling
pathway results in Ca2 mobilization [17^21]. Ago-
nist binding to these receptors stimulates phospholip-
ase C (PLC) activity. Depending upon the receptor
type, PLC is stimulated either through the heterotri-
meric G-proteins, GK or GL=Q subunits, leading to the
activation of PLC-L isozyme or via the tyrosine au-
tophosphorylation and activation of PLC-Q isozyme
[17,18,22]. Both of these PLC isozymes catalyze the
hydrolysis of a plasma membrane phospholipid,
phosphatidylinositol 4,5-bisphosphate, and the co-re-
lease of the second messengers IP3 and diacylglycer-
ol. The lipophilic diacylglycerol stimulates protein
kinase C, while IP3 is released into the cytosol where
it interacts with an IP3 receptor Ca2 channel (IP3R)
that releases Ca2 stored within the endoplasmic re-
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ticulum (ER). An additional e¡ect of elevating IP3
levels and the subsequent depletion of luminal Ca2
from within the stores is an activation of Ca2 in£ux
across the plasma membrane.
When examined with su⁄cient spatial and tempo-
ral resolution, single cell [Ca2]c responses are often
varied and complex [21]. Cobbold and coworkers [23]
were the ¢rst group to directly demonstrate that hor-
mones acting through receptors coupled to PLC ac-
tivation generate periodic baseline-separated [Ca2]c
spikes, or oscillations, in aequorin-injected hepato-
cytes. This initial observation was subsequently con-
¢rmed in our laboratory using £uorescence imaging
techniques [24,25]. The amplitude of baseline-sepa-
rated [Ca2]c spikes is not a¡ected by agonist dose,
but rather increasing agonist concentration results in
an increase in spiking frequency. This phenomenon
has been described as frequency-modulated Ca2 sig-
naling [21,24,26,27]. It has been suggested that intra-
cellular Ca2-sensitive processes can be regulated
with much greater accuracy by low frequency
[Ca2]c spikes than by the equivalent time-averaged
[Ca2]c signal, which would yield only a slight eleva-
tion of [Ca2]c above the basal state. The intracellu-
lar targets of these [Ca2]c oscillations are expected
to integrate the incoming Ca2 signal in a manner
that will depend on their rates of activation and in-
activation in response to the [Ca2]c spikes [28,29].
Another important property of hepatic Ca2 signals
is that each [Ca2]c spike originates from a speci¢c
subcellular locus and propagates across the cell in the
form of an intracellular [Ca2]c wave or tide. Once
initiated, the [Ca2]c waves propagate at ¢xed veloc-
ity regardless of the agonist or dose. Because Ca2
has a limited di¡usion coe⁄cient in the cytosol [30],
propagating [Ca2]c waves may provide a mechanism
to deliver localized Ca2 release to distal parts of the
cell [21]. Furthermore, both IP3 and Ca2 can pass
through the gap junctions between cells, resulting
in intercellular [Ca2]c waves that can propagate
between interconnected cells ([31^33]; reviewed
in [34]). We have also shown that intercellular
Ca2 waves can propagate across entire lobules in
the intact perfused rat liver, reaching distances
of 500^1000 Wm [21,35^37]. The physiological rele-
vance of these intercellular [Ca2]c waves may be to
coordinate the activity of functional units of the
liver.
3. Relationship between [Ca2+]c and [Ca2+]m
Regulation of mitochondrial metabolism by tran-
sient elevations in [Ca2]c requires that some of the
released Ca2 be transferred into the mitochondrial
matrix. Mitochondria contain their own speci¢c
Ca2 transport systems regulating [Ca2]m [38,39].
The uptake of Ca2 into the mitochondria is medi-
ated by an electrogenic uniporter driven by the mi-
tochondrial membrane potential, whereas Ca2 e¥ux
occurs by either Na/Ca2 or H/Ca2 exchange car-
riers, with the latter predominating in the liver. Iso-
lated mitochondria do not accumulate large amounts
of Ca2 in the presence of physiological extracellular
Ca2 concentrations. This is due to the sigmoidal
activation kinetics and low a⁄nity of the electrogenic
uniporter for Ca2, which has a K0:5 of 5^10 WM
[40,41]. The amplitude of IP3-dependent [Ca2]c
spikes is in the order of two- to ¢ve-fold above the
baseline [Ca2]c values, reaching a peak of 200^1000
nM [Ca2]c [42]. In this range of free Ca2 concen-
trations, uniporter activation in isolated mitochon-
dria is remarkably slow, requiring 30^60 s, suggest-
ing that mitochondria would not accumulate
signi¢cant amounts of Ca2 during a brief [Ca2]c
spike. However, a variety of glucogenic hormones
have been shown to stimulate mitochondrial metab-
olism in a Ca2-dependent manner in isolated hepa-
tocytes and the perfused liver. These hormones
activate oxygen uptake, increase pyruvate dehydro-
genase activity, enhance the reduction of NAD(P)
and stimulate £ux through ATP-requiring pathways
such as gluconeogenesis and urea synthesis (reviewed
in [3,5]).
A possible explanation for the apparent discrep-
ancy between Ca2 uptake by isolated mitochondria
and the Ca2-dependent regulation of mitochondrial
function in situ was provided by Rizzuto et al. [43^
45]. In these population studies, [Ca2]m was meas-
ured in living cells by expressing the Ca2-sensitive
photoprotein aequorin targeted to the mitochondria.
These authors showed that IP3-mediated mobiliza-
tion of intracellular Ca2 stores resulted in large,
rapid [Ca2]m increases, which occurred in parallel
with the [Ca2]c increases invoked by the same hor-
mone treatment. Mean [Ca2]m increases were sev-
eral fold higher than the changes observed in mean
[Ca2]c. By contrast, other mechanisms of elevating
BBABIO 44662 28-7-98 Cyaan Magenta Geel Zwart
L.D. Robb-Gaspers et al. / Biochimica et Biophysica Acta 1366 (1998) 17^32 19
[Ca2]c (e.g. stimulated Ca2 in£ux) were much less
e¡ective in elevating [Ca2]m, despite a similar
change in the global [Ca2]c level [44]. Furthermore,
in permeabilized cell studies, an increase in the me-
dium free Ca2 concentration to 1^2 WM caused slow
mitochondrial Ca2 accumulation, whereas Ca2 re-
lease from the IP3-sensitive stores in the presence of
EGTA dramatically elevated [Ca2]m. These data
suggest that the mitochondria are closely juxtaposed
to the IP3R Ca2-release sites, such that IP3-depend-
ent Ca2 release gives rise to localized, but short
lived, domains of high [Ca2]c that are sensed by
the mitochondrial Ca2 uptake sites (Fig. 1). In ad-
dition to the strategic localization of the mitochon-
dria to the IP3-sensitive Ca2 stores in HeLa cells
and hepatocytes (see below), it is now apparent
that in some cell types mitochondria can accumulate
large amounts of Ca2 during membrane depolariza-
tion and plasma membrane Ca2-in£ux [46^49]. This
suggests that voltage-sensitive Ca2 channels and
Ca2-in£ux channels could also regulate mitochon-
drial metabolism. The e⁄cient uptake of Ca2 by
the mitochondria during rapid localized Ca2 mobil-
ization into the cytosol could result from the rela-
tively high levels of [Ca2]c achieved in these do-
mains. However, it could also be a function of the
rapid uptake mode of the mitochondrial uniporter,
which has been reported to yield a burst of Ca2
uptake in response to rapid changes in extramito-
chondrial Ca2 [50].
It is now becoming clear that mitochondria are not
just passive participants in cellular Ca2 signaling
pathways. This organelle’s large capacity to accumu-
late Ca2, coupled with the strategic localization of
Ca2 release channels with mitochondrial Ca2 up-
take sites, o¡ers the potential for the mitochondria to
modulate the rate of rise and the magnitude of the
[Ca2]c spike during a physiological stimulus. In ad-
dition, the export of accumulated Ca2 back into the
cytosol during the decay phase after a stimulus can
delay the recovery of [Ca2]c to baseline values [51^
55]. In some cell types, mitochondrial Ca2 uptake is
su⁄cient to induce a transient opening of the perme-
ability transition pore, resulting in a rapid e¥ux of
accumulated Ca2 into the cytosol and ampli¢cation
of the original [Ca2]c signal [56]. This process has
Fig. 1. Schematic diagram showing mitochondrial Ca2 uptake sites in juxtaposition to the IP3-sensitive Ca2 release channel. The in-
tramitochondrial Ca2-sensitive targets, pyrophosphatase (PPase), 2-oxoglutarate dehydrogenase (OGDH) and pyruvate dehydrogenase
(PDH), are also illustrated.
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been described as mitochondrial Ca2-induced Ca2
release. In addition to shaping the pro¢le of a [Ca2]c
spike during stimulation, mitochondrial Ca2 accu-
mulation is capable of modulating the activity of
intracellular Ca2 release channels and store-oper-
ated, Ca2-in£ux channels ([57,58]; Hajno¤czky and
Thomas, in preparation).
In our imaging studies with primary cultured hep-
atocytes, we have used £uorescent Ca2 indicators to
investigate the relationship between [Ca2]c and
[Ca2]m at the single cell and subcellular level ([59];
Robb-Gaspers et al., in preparation). Fura2 loaded
as the acetoxymethyl (AM) ester is predominantly
localized in the cytosol of these cells, whereas
rhod2 is largely accumulated into the mitochondria,
presumably because rhod2 is positively charged in
the AM-ester form. The mitochondrial localization
of rhod2 can be further enhanced by incubating the
cells for several hours or overnight, during which
time plasma membrane e¥ux pathways eliminate
the residual cytosolic dye without eliminating the
mitochondrial loading (fura2/AM is then loaded
shortly before carrying out the experiment). Fig. 2
(left panels) shows confocal images of rhod2 £uores-
cence in an intact hepatocyte before and after vaso-
pressin treatment. The rhod2 £uorescence was rela-
tively low prior to vasopressin addition, but rapidly
increased in the presence of the hormone, indicating
Fig. 2. Confocal image series showing spatial organization of [Ca2]m increases in a hepatocyte stimulated with 50 nM vasopressin
(VP) for 30 s. Left column, rhod2 £uorescence; middle column, Mito Tracker Green (MTG) £uorescence; right column, rhod2/MTG
£uorescence ratio. The color blue codes for a low ratio while red codes for higher ratios. Ratio changes greater than 3.0-fold have
been pseudocolored to appear red. Note that the highest [Ca2]m increases occurs in the periphery of the cell.
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a substantial increase in [Ca2]m. The tubular nature,
typical of mitochondria in these cells, is most appar-
ent in the brighter image obtained after vasopressin
treatment, but the structure is the same in the basal
state. Direct identi¢cation of these structures as mi-
tochondria was achieved by dual labeling with the
Fig. 3. Relationship between [Ca2]c and [Ca2]m. Primary cultured hepatocytes were co-loaded with fura2/AM, to measure [Ca2]c,
and rhod2/AM, to measure [Ca2]m, as described in Hajno¤czky et al. [59]. Mitochondrial localization of rhod2 was con¢rmed by the
addition of the uncoupler, 1799 (5 Wg/ml), plus oligomycin (1 Wg/ml) (UNC). The agonist or thapsigargin was added at the arrow and
present continuously throughout the experiment. (A) Simultaneous measurements of [Ca2]c and [Ca2]m spiking in a single phenyl-
ephrine-stimulated (PE) hepatocyte. (Insert) First two [Ca2] oscillations replotted on an expanded time scale showing [Ca2]m closely
follows changes in [Ca2]c. (B) Simultaneous measurements of [Ca2]c and [Ca2]m changes in a single hepatocyte stimulated with
high vasopressin (VP). (Insert) [Ca2]c and [Ca2]m responses replotted on a expanded time scale. (C) Thapsigargin-induced changes
in [Ca2]c and [Ca2]m. Mean population Ca2 responses from two parallel hepatocyte cultures loaded with either fura2 or rhod2. (In-
sert) Simultaneous measurements of [Ca2]c and [Ca2]m changes in a single hepatocyte treated with thapsigargin (Tg). Note the diver-
gence between the slow mitochondrial Ca2 accumulation and slow increases in [Ca2]c.
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mitochondrial-speci¢c vital stain, Mito Tracker
Green [60]. The middle panels of Fig. 2 show the
Mito Tracker Green £uorescence images obtained
simultaneously with the equivalent rhod2 images
(left) using dual emission confocal microscopy. There
was no change in either the £uorescence intensity or
distribution of Mito Tracker Green following vaso-
pressin treatment. In the rightmost panels of Fig. 2,
the ratio of rhod2 to Mito Tracker Green £uores-
cence is displayed in pseudocolor. It is clear from
these pseudocolor images that the two dyes were
co-localized throughout the cell. However, the
rhod2 £uorescence increase induced by vasopressin
was largest in the periphery of the cell, suggesting
that [Ca2]m may be increased to a greater extent
in this subcellular region. This pattern of response
was consistently observed in vasopressin-stimulated
hepatocytes, however the kinetics of [Ca2]m changes
were similar in all regions of the cell.
As reported in a number of previous studies
[24,25,59], treatment of hepatocytes with submaximal
doses of vasopressin results in oscillations of [Ca2]c.
These [Ca2]c oscillations are a classic example of
frequency modulation, whereby the hormone dose
does not a¡ect the amplitude of the individual
[Ca2]c spikes, but the frequency of oscillations in-
creases in a dose-dependent manner. Fig. 3A shows
simultaneous measurements of [Ca2]c and [Ca2]m
in cells co-loaded with fura2 and rhod2. The K1-ad-
renergic agonist, phenylephrine, was added at the
arrow and was present continuously to the end of
the trace. This agonist treatment induced oscillations
of [Ca2]c, which were closely tracked by oscillations
of [Ca2]m. The inset to the right shows the ¢rst two
[Ca2]c and [Ca2]m spikes on an expanded time
scale. Thus, oscillations of [Ca2]c induced by treat-
ment of hepatocytes with IP3-dependent agonists are
rapidly transmitted to mitochondria. This is consis-
tent with the original conclusions reached by Rizzuto
et al. [43^45] regarding the coupling of IP3-depend-
ent Ca2 release from intracellular stores to facilitate
Ca2 uptake into the mitochondria. Our studies [59]
were the ¢rst to demonstrate that this phenomenon
allows [Ca2]c oscillations to be transmitted to the
mitochondria to yield [Ca2]m oscillations. Further-
more, these experiments provided a direct kinetic
comparison between the Ca2 changes in the two
compartments of individual cells through simultane-
ous measurements with compartmentalized £uores-
cent Ca2 indicator dyes. Direct evidence that the
fura2 and rhod2 were reporting Ca2 changes from
the cytosol and mitochondria, respectively, comes
from the e¡ects of uncoupler (added in the presence
of oligomycin to block mitochondrial ATPase activ-
ity). Uncoupler treatment caused a loss of [Ca2]m
with a concomitant increase in [Ca2]c (Fig. 3A^C).
Experiments using thapsigargin to inhibit the ER
Ca2 pump and elevate [Ca2]c by IP3-independent
mechanisms, provided further evidence for the priv-
ileged access of mitochondria to Ca2 released via
the IP3R. In contrast to the close coupling between
[Ca2]c and [Ca2]m during [Ca2]c oscillations in-
duced by IP3-linked hormones, there was a signi¢-
cant lag in the mitochondrial uptake of Ca2 mobi-
lized in response to thapsigargin (Fig. 3C).
Moreover, at lower levels of thapsigargin that re-
leased Ca2 more slowly but still gave a similar
peak amplitude of [Ca2]c (presumably as a result
of capacitative Ca2 in£ux from the extracellular me-
dium [61]), there was almost no change in [Ca2]m
[59]. Thus, it appears that the coupling of [Ca2]c
and [Ca2]m oscillations is a property of the close
physical association of ER Ca2 release sites and
mitochondrial Ca2 uptake sites.
Treatment of hepatocytes with high levels of vaso-
pressin yields a non-oscillatory, sustained increase in
[Ca2]c, as reported previously and shown in Fig. 3B.
The [Ca2]m increase observed under these condi-
tions occurred as a single transient that decayed to
basal with kinetics that were only slightly slower
than the [Ca2]m spikes observed during [Ca2]c os-
cillations. This somewhat unexpected observation
can also be explained on the basis of close coupling
between IP3-dependent Ca2 release from the ER
and subsequent mitochondrial Ca2 uptake. In con-
trast to the situation with submaximal hormone
doses, where the Ca2 release channels open and
close periodically, the IP3R channels remain contin-
uously open in the presence of high levels of vaso-
pressin [62]. As a result, the ER becomes depleted of
Ca2 and the £ux of Ca2 through the IP3R is
greatly reduced. Under these conditions any local
gradient of Ca2 is likely to dissipate and there will
be no large driving force for Ca2 uptake into the
mitochondria (Fig. 1). This allows the mitochondrial
Ca2 e¥ux pathways to predominate so that the
BBABIO 44662 28-7-98 Cyaan Magenta Geel Zwart
L.D. Robb-Gaspers et al. / Biochimica et Biophysica Acta 1366 (1998) 17^32 23
[Ca2]m increase is only transient despite the sus-
tained elevation of [Ca2]c. These data could also
potentially be explained on the basis of the short-
lived nature of a rapid uptake mode of mitochon-
drial Ca2 accumulation described by Gunter and
coworkers [50]. Regardless of the mechanism, the
limited duration of mitochondrial Ca2 sequestration
during a sustained increase in [Ca2]c elicited by IP3-
dependent hormones, may serve an important func-
tion in preventing mitochondrial Ca2 overload. An
important consequence of this property of mitochon-
drial Ca2 uptake is that [Ca2]c oscillations are
much more e¡ective in transmitting a prolonged
Ca2 signal to the mitochondria than is a sustained
increase of [Ca2]c. In e¡ect, the mitochondria can
tune out sustained [Ca2]c signals, whereas oscilla-
tions of [Ca2]c provide a means to deliver a pro-
longed Ca2 stimulus to the mitochondria. As will
be discussed below, the intramitochondrial targets of
this calcium signaling can apparently integrate the
oscillating [Ca2]m signal to give a damped or even
smooth output response at the level of mitochondrial
metabolism.
4. [Ca2+]c oscillations and metabolic output
Transfer of Ca2 from the cytosol to the mito-
chondria has been suggested to regulate mitochon-
drial oxidative metabolism [4,45,52,59,63,64]. Mc-
Cormack and Denton [4] demonstrated that
elevations of [Ca2]m within the physiological range
stimulate the Ca2-sensitive intramitochondrial dehy-
drogenases: PDH, OGDH and NAD-ICDH. This
leads to increased intramitochondrial NAD(P)H lev-
els and subsequent enhanced £ux through the respir-
atory chain. Furthermore, Koretsky and Balaban
[65] have reported that an increase in NAD(P)H lev-
els can stimulate the rate of respiration in isolated rat
liver mitochondria in the presence of subsaturating
extramitochondrial ADP (i.e. between state 4 and
state 3 respiratory rates). These authors suggested
that elevated NAD(P)H levels augment the maximal
velocity of oxidative phosphorylation. This mecha-
nism could increase mitochondrial ATP production
during cellular activation without a measurable shift
in the cytosolic ATP/ADP ratio. This is consistent
with NMR experiments conducted on the in situ
dog heart, where an increase in cardiac work load
dramatically stimulated oxygen uptake without de-
tectable changes in ATP, ADP or inorganic phos-
phate [1,66].
We have investigated the relationship between
[Ca2]c spiking frequency and the level of NAD(P)H
reduction in single primary cultured hepatocytes
loaded with a low concentration of fura2/AM. Using
this dye loading procedure, it is possible to monitor
changes in [Ca2]c and NAD(P)H without signi¢cant
spillover of the fura2 £uorescence into the Ca2-in-
sensitive excitation wavelength (360 nm) where we
monitor NAD(P)H changes ([59]; Robb-Gaspers et
al., in preparation). Fig. 4A^C shows simultaneous
measurements of [Ca2]c and NAD(P)H in three sep-
arate hepatocytes stimulated with phenylephrine. To
facilitate comparison between [Ca2]c responses and
activation of mitochondrial metabolism, NAD(P)H
changes were normalized to the peak 360 nm £uo-
rescence intensity measured after the addition of ro-
tenone plus L-hydroxybutyrate (not shown). Phenyl-
ephrine was added at the arrow and was present
continuously throughout the experiment. Agonist
stimulation induced a range of di¡erent intensities
of [Ca2]c response in these cells, from a single spike
(Fig. 4A), 0.24 spikes/min (Fig. 4B) to 0.5 spikes/min
(Fig. 4C). The initial [Ca2]c spike was followed by
an increase in cellular NAD(P)H £uorescence, which
is predominately of mitochondrial origin [59,67]. The
rising phase of the NAD(P)H response started 2^3 s
after the increase in [Ca2]c, which probably re£ects
the time required for released Ca2 to activate the
Ca2-sensitive intramitochondrial dehydrogenases.
At the termination of the [Ca2]c spike, [Ca2]c levels
quickly returned to baseline values, whereas com-
plete NAD(P)H oxidation was much slower requir-
ing 5^10 min (Fig. 4A). We have previously shown
that each NAD(P)H spike is paralleled by a reduc-
tion in the mitochondrial £avoproteins, which occurs
with similar kinetics to the NAD(P)H changes [59].
Due to the relatively slow reoxidation phase, mito-
chondrial redox spikes fused together at [Ca2]c os-
cillation frequencies above 0.5 spikes/min (Fig. 4C;
see also [59]) generating an essentially sustained met-
abolic output. A similar relationship between [Ca2]c
responses and changes in intramitochondrial
NAD(P)H levels has also been reported in adrenal
glomerulosa cells and pancreatic L-cells [68,69]. In
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hepatocytes, each [Ca2]c spike resulted in an in-
crease in NAD(P) reduction to approximately 50^
60% of the maximal response obtained in the pres-
ence of rotenone plus L-hydroxybutyrate. This mag-
nitude of NAD(P)H increase was independent of the
[Ca2]c spiking frequency (Fig. 4), suggesting that the
mitochondria were activated to a similar extent by
each individual [Ca2]c spike. However, the time
averaged response is clearly dependent on the
[Ca2]c spiking frequency, which is determined by
the strength of the hormonal stimulus.
Maximal hormone doses resulting in a non-oscil-
latory, sustained elevation in [Ca2]c do not cause a
sustained elevation in mitochondrial NAD(P)H lev-
els (Fig. 5). This would be predicted from data illus-
trated in Fig. 3B, showing that supramaximal vaso-
pressin doses only transiently elevate [Ca2]m even
though [Ca2]c remains high. This is due to the de-
pletion of internal Ca2 stores in the continuing pres-
ence of high levels of IP3, as described above (see
also Fig. 1). The rate of NAD(P)H reoxidation is
slow relative to the fall in [Ca2]m (compare Figs.
3B and 5) and decayed with similar kinetics to the
NAD(P)H oxidation rate observed following a single
[Ca2]c spike. Thus, maximal sustained activation of
the intramitochondrial dehydrogenases can appar-
Fig. 5. A sustained elevation in [Ca2]c does not result in a sus-
tained increase in NAD(P)H levels. Hepatocytes were loaded
with low a level of fura2/AM, as described in Hajno¤czky et al.
[59], and NAD(P)H and [Ca2]c responses to high vasopressin
stimulation were monitored simultaneously in a single hepato-
cyte.
Fig. 4. Relationship between [Ca2]c spiking frequency and lev-
els of NAD(P)H. Primary cultured hepatocytes were loaded
with a low level of fura2/AM, as described in Hajno¤czky et al.
[59], and NAD(P)H and [Ca2]c responses to phenylephrine
were monitored simultaneously in single hepatocytes. Changes
in NAD(P)H £uorescence were monitored at 360 nm excitation,
while fura2 £uorescence intensity changes were monitored at
340 and 380 nm excitation. NAD(P)H responses were normal-
ized to the peak 360 nm £uorescence intensity changes obtained
in the presence of rotenone and L-hydroxybutyrate (not
shown).
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ently be achieved with an oscillatory [Ca2]c signal of
su⁄ciently high frequency, but dehydrogenase acti-
vation cannot be maintained by the continuous ele-
vation of [Ca2]c elicited by maximal hormone doses.
Although the rising phase of NAD(P)H correlates
well with the transient rise of [Ca2]m, the declining
phase of the redox response is remarkably slower
than would be predicted from the decay of [Ca2]m.
One possible explanation for this discrepancy is that
the rephosphorylation and consequent inactivation
of PDH may be relatively slow [59]. We have directly
tested this hypothesis in primary cultured hepato-
cytes stimulated with a maximal vasopressin dose.
This protocol e¡ectively synchronizes [Ca2]c and
[Ca2]m responses in an entire cell population, allow-
ing measurements of the metabolic events underlying
the changes in mitochondrial NAD(P)H levels. This
method of synchronizing the Ca2 responses of the
cell population also allowed us to obtain calibrated
[Ca2]m measurements using mitochondrial-targeted
aequorin transiently transfected into cultured hepa-
tocytes. The traces in Fig. 6 show the mean changes
in the dephosphorylated, active form of PDH
(PDHa), and the corresponding mean [Ca2]m re-
sponses following maximal vasopressin stimulation.
As predicted, there was a rapid increase in PDHa
following agonist addition, which closely followed
the rising phase of [Ca2]m and correlated with the
increase in NAD(P)H. This is consistent with rapid
uptake of Ca2 released from the ER into the
mitochondrial matrix, as previously proposed
[44,45,59,64] and illustrated schematically in Fig. 1.
Calibration of the mitochondrial-targeted aequorin
revealed a peak [Ca2]m of 2 WM at 20 s, which
then declined to the basal level over the next 2
min. The transient elevation in [Ca2]m reported by
mitochondrial aequorin in hepatocyte populations
was also observed using rhod2 to measure [Ca2]m
in single cells (Figs. 3B and 6). PDHa rose to a tran-
sient plateau at 30 s, but rather than declining once
[Ca2]m had decreased, there was a larger secondary
increase in PDHa beginning approximately 90 s after
vasopressin stimulation. Therefore, the time-depend-
ent changes in PDHa alone cannot explain the slow
kinetics of NAD(P)H reoxidation following a
[Ca2]m spike.
As discussed above, only the initial activation of
PDH could be assigned to changes in [Ca2]m in
primary cultures of hepatocytes. This is in contrast
to the clear correlation between changes in [Ca2]m
and PDHa in a ¢broblast cell line studied by Rutter
et al. [64]. The secondary increase of PDHa in hep-
atocytes probably re£ects alterations in the levels of
metabolic regulators of the PDH kinase that phos-
phorylates and inactivates the PDH complex. PDH
kinase is allosterically activated by increases in the
intramitochondrial ratios of ATP/ADP, NADH/
NAD or acetyl CoA/CoA [70]. Under our experi-
mental conditions, high vasopressin stimulation re-
sulted in a 20% drop in hepatic cellular ATP levels,
which then remained stable for at least 10 min. The
decline in cellular ATP is expected to lower the mi-
tochondrial ATP/ADP ratio and in combination with
the reoxidation of NAD(P)H should result in inhib-
ition of PDH kinase activity. We found no evidence
that changes in the acetyl CoA/CoA ratio was in-
volved in the secondary activation phase of PDH.
Thus, it appears that the Ca2-independent, second-
ary rise in PDHa is mediated through the complex
Fig. 6. Correlation between [Ca2]m changes and PDH activity.
Primary cultured hepatocytes were transiently transfected with
mitochondrial-targeted aequorin as described in Rutter et al.
[64]. Aequorin luminescence from cell populations was moni-
tored during high vasopressin (VP) stimulation and converted
into [Ca2]m changes as described in Rutter et al. [49]. The
trace is the mean from seven measurements on separate cul-
tures. Dashed line represents the baseline [Ca2]m values at lat-
er time points. Mean PDHa activity was measured in parallel
hepatocyte cultures after stimulation with high vasopressin
(n = 4 cell preparations). PDHa activity was assayed as de-
scribed in [64,83] and plotted as a percentage of the total PDH
activity.
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alterations in mitochondrial ATP/ADP and NADH/
NAD ratios (Robb-Gaspers et al., in preparation).
The fact that NAD(P)H levels declined in the face
of increasing PDHa, suggested that £ux through the
mitochondrial respiratory chain might be enhanced.
In addition, these data indicated that an enhanced
rate of NAD(P)H utilization must persist long after
[Ca2]m levels returned to baseline values. These data
directed our attention to the previously reported ef-
fects of Ca2-mobilizing hormones on respiratory
chain activity and the mitochondrial proton motive
force, as a possible explanation for the oxidation of
NAD(P)H following activation of intramitochondrial
dehydrogenases by [Ca2]m spikes in hepatocytes.
5. [Ca2+]c and mitochondrial proton motive force
Isolation of mitochondria from rats following
acute systemic administration of Ca2-mobilizing
hormones results in a general, persistent stimulation
of mitochondrial processes such as increased state 3
and uncoupler-stimulated respiratory rates [7,71].
Analogous studies in isolated hepatocytes and per-
fused rat liver have demonstrated that Ca2-mobiliz-
ing hormones also stimulate the rate of oxygen up-
take in these preparations [7,67,72^74]. Since the
e¡ect of Ca2-mobilizing hormones on mitochon-
drial respiratory rates is still observed in isolated
mitochondria and even submitochondrial particles
[75], it is probable that the hormonal stimulation of
oxygen consumption results from a direct e¡ect on
the respiratory chain. Halestrap and coworkers [7,76]
have suggested that this may be mediated through
inhibition of a Ca2-sensitive pyrophosphatase, lead-
ing to accumulation of inorganic pyrophosphate
that triggers an increase in mitochondrial volume.
However, pyrophosphate accumulation cannot ex-
plain increased respiratory rates in inverted submito-
chondrial particles. Regardless of the speci¢c mech-
anism, stimulation of respiratory chain activity is
expected to result in an increase in the mitochondrial
proton motive force (PMF). The PMF is composed
of membrane potential (v8m) and pH gradient
(vpHm) components. Although an increase in PMF
has been reported in the perfused rat liver using
a freeze-fractionation approach [77,78], increases
in PMF have not been observed consistently in
isolated hepatocytes or mitochondria isolated from
livers stimulated with Ca2-mobilizing hormones
[7,79].
We have reinvestigated the relationship between
hormone-induced elevations of [Ca2]c and the
Fig. 7. Relationship between a sustained elevation in [Ca2]c
and mitochondrial proton motive force. Hepatocytes were co-
loaded with fura2/AM and tetramethyl rhodamine ethyl ester
(TMREE) to measure [Ca2]c and mitochondrial membrane po-
tential (v8m), or with fura2/AM and £uorescein diacetate to
measure [Ca2]c and mitochondrial proton gradients (vpHm) as
described by Robb-Gaspers et al. (in preparation). Vasopressin
(50 nM) was added at the arrow and present continuously
throughout the experiment. (A) [Ca2]c and v8m measured si-
multaneously in a single hepatocyte stimulated with high vaso-
pressin. The TMREE £uorescence trace was normalized to a
maximal range of v8m by hyperpolarizing the mitochondrial
inner membrane with nigericin (Nig), followed by uncoupler
plus oligomycin to completely collapse the PMF (not shown).
(B) [Ca2]c and vpHm measured simultaneously in a single hep-
atocyte stimulated with high vasopressin. The £uorescein £uo-
rescence trace was normalized to the £uorescence values obtain
after collapsing PMF with the addition of the uncoupler, 1799
(5 Wg/ml), plus oligomycin (1 Wg/ml) (UNC).
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PMF by monitoring v8m and vpHm in primary cul-
tured hepatocytes using newly developed £uorescence
imaging techniques. This method allows changes in
mitochondrial PMF to be monitored in real-time in
single hepatocytes and down to the level of individ-
ual mitochondria in situ (Robb-Gaspers et al., in
preparation). In these studies, primary cultured hep-
atocytes were co-loaded with fura2/AM and either
tetramethyl rhodamine ethyl ester (TMREE), a mi-
tochondrial membrane potential-sensitive dye, or the
weak acid £uorescein, which distributes across the
mitochondrial inner membrane according to vpHm
[80,81].
The traces in Fig. 7 show simultaneous measure-
ment of [Ca2]c and v8m, or [Ca2]c and vpHm in
single hepatocytes stimulated with a maximal vaso-
pressin dose. The vasopressin was added at the arrow
and was present continuously throughout the experi-
ment. As previously reported and shown in Figs. 3B
and 5, the addition of a maximal vasopressin dose
resulted in a rapid, sustained increase in [Ca2]c. In
contrast to the prediction that v8m might decrease
during mitochondrial Ca2 uptake, both TMREE
and £uorescein £uorescence intensities increased sig-
ni¢cantly following maximal vasopressin treatment,
indicating increases in both v8m and vpHm. During
mitochondrial Ca2 uptake an increase in vpHm
might be excepted due to compensating H move-
ment. However, Ca2 uptake was brief and essen-
tially complete after 20^30 s (Figs. 3B and 6), where-
as the increase in vpHm occurred with a slower time-
course and was more persistent (Fig. 7B), suggesting
that the changes observed in vpHm were not a direct
consequence of Ca2 uptake. The addition of the
K/H ionophore, nigericin (Nig), to hyperpolarize
the mitochondrial inner membrane, caused a further
increase in TMREE £uorescence intensity (Fig. 7A),
whereas the addition of uncoupler plus oligomycin
(UNC) to completely collapse the mitochondrial
PMF decreased £uorescein £uorescence intensity
(Fig. 7B). These data demonstrate that both dyes
e¡ectively report the changes in mitochondrial
PMF across the mitochondrial inner membrane.
The rates of rise of the mitochondrial PMF compo-
nents were much slower than the changes in either
[Ca2]c and [Ca2]m, reaching peak values 5^10 min
after agonist addition (Fig. 7). However, the in-
creases in v8m and vpHm paralleled the time course
of mitochondrial NAD(P)H reoxidation and the sec-
ondary rise in PDH activity (compare Fig. 7 with
Figs. 5 and 6). While the changes in mitochondrial
PMF were more prolonged than the NAD(P)H re-
sponses, they returned towards basal values 20^30
min after agonist stimulation (Fig. 7).
The vasopressin-induced increases in v8m and
vpHm do not appear to be a secondary consequence
of enhanced respiratory substrate supply. Thus, ad-
dition of acetoacetate or L-hydroxybutyrate to oxi-
dize or reduce the mitochondrial redox couple, re-
spectively, did not signi¢cantly a¡ect the magnitude
of mitochondrial PMF changes (Robb-Gaspers et al.,
in preparation). We have shown that the addition of
ketone bodies to primary cultured hepatocytes can
signi¢cantly alter matrix NAD(P)H levels ([59],
Robb-Gaspers et al., in preparation). Furthermore,
current evidence in the literature indicates that there
is a linear relationship between mitochondrial
NADH levels and oxygen consumption in both iso-
lated mitochondria and hepatocyte suspensions
[6,65]. Taken together, these data suggest that
changes in matrix NADH/NAD ratio alone are
not su⁄cient to modulate mitochondrial PMF. This
is consistent with a the data of Brown et al. [6] which
showed that changes in matrix NAD(P)H levels
could not fully account for the increased respiratory
rate observed in vasopressin-stimulated hepatocyte
suspensions [65].
An alternative mechanism that could account for
the elevation of the PMF would be an inhibition of
the pathways that dissipate the proton gradient. A
potential candidate for this is the mitochondrial ATP
synthase, which has been reported to be inhibited by
mitochondrial Ca2 uptake [82]. These authors dem-
onstrated that micromolar Ca2 inhibits the ATP
synthase of Ehrlich ascites tumor cells, and suggested
that this occurred through association of a Ca2-sen-
sitive inhibitor protein with the ATP synthase [82].
Thus, mitochondrial Ca2 uptake could inhibit the
ATP synthase leading to an increase in PMF, reduc-
tion in matrix NAD(P)H and a drop in cellular ATP
levels. If the changes in PMF we observed in primary
cultured hepatocytes were due to a Ca2-dependent
inhibition of the mitochondrial ATP synthase, then
the increases in PMF following vasopressin stimula-
tion should not be observed in oligomycin-treated
cells. The traces in Fig. 8 show simultaneous meas-
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urements of [Ca2]c and v8m, or [Ca2]c and vpHm
in single hepatocytes preincubated with oligomycin
prior to stimulation with a high vasopressin dose.
As excepted for the blockage of proton £ux through
the F0 channel, the addition of oligomycin caused an
increase in both v8m and vpHm (Fig. 8). The addi-
tion of a maximal vasopressin dose still resulted in a
rapid, sustained increase in [Ca2]c, which was still
followed by an increase in both v8m and vpHm (Fig.
8). The addition of nigericin caused reciprocal
changes in v8m and vpHm, leading to maximal
v8m levels and a slow collapse of vpHm (Fig. 8).
The subsequent addition of uncoupler, either FCCP
(Fig. 8A) or 1799 (Fig. 8B), resulted in the complete
collapse of both PMF parameters. These data indi-
cate clearly that most of the vasopressin-stimulated
increase in mitochondrial PMF is not through an
inhibition of the F1/F0 ATP synthase. Further evi-
dence that the vasopressin-induced increase in PMF
is not due to blockage of a proton-dissipative path-
way comes from the previous observations showing a
prolonged increase in oxygen consumption in both
isolated hepatocytes and perfused rat liver in re-
sponse to Ca2-mobilizing agonists [4,7,65,67,73,
74]. Thus, it is most likely that Ca2-mobilizing hor-
mones elevate mitochondrial PMF through a direct
e¡ect on the respiratory chain, which cannot be du-
plicated by increasing matrix NAD(P)H levels.
Utilizing high resolution confocal microscopy, we
have determined the concentration gradients across
the mitochondrial inner membrane for each indicator
dye. Using these data, we estimated that maximal
vasopressin stimulation results in a 20% increase in
total mitochondrial PMF (Robb-Gaspers et al., in
preparation). This is the ¢rst direct demonstration
that hormonal stimulation increases total PMF in
intact cells. If the enhancement of mitochondrial
PMF is the direct result of an increase in respiratory
chain £ux, this may explain why intramitochondrial
NAD(P)H levels fall, whilst PDHa levels increase.
Vasopressin also enhanced mitochondrial PMF at
the lower hormone doses that generated oscillatory
[Ca2]c signals. As reported previously for NAD(P)H
responses (Fig. 4), submaximal vasopressin modu-
lated both v8m and vpHm in a frequency-dependent
manner. Discrete oscillations in each of these param-
eters could be observed at low [Ca2]c spiking fre-
quencies which fused into a sustained increase in
PMF at higher agonist concentrations. The sustained
increase in both v8m and vpHm was manifest at
lower [Ca2]c spiking frequencies than the NAD(P)H
responses (Robb-Gaspers and Thomas, unpublished
observations). Taken together, our data demonstrate
that oscillatory [Ca2]c signals are a more e¡ec-
tive mechanism to regulate both mitochondrial
Fig. 8. E¡ect of oligomycin pretreatment on vasopressin-stimu-
lated elevation in mitochondrial proton motive force. Hepato-
cytes were co-loaded with fura2/AM and the appropriate PMF
indicator as described in Fig. 7. Additions are indicated by the
arrows and the compound was present continuously throughout
the experiment. The additions are oligomycin (Oligo; 5 Wg/ml),
vasopressin (VP; 50 nM), nigericin (Nig; 1 WM), FCCP (5 WM)
or 1799 (5 Wg/ml). (A) [Ca2]c and v8m measured simultane-
ously in a single hepatocyte. The TMREE £uorescence trace
was normalized to a maximal range of v8m by hyperpolarizing
the mitochondrial inner membrane with nigericin (Nig), fol-
lowed by FCCP to collapse the PMF. (B) [Ca2]c and vpHm
measured simultaneously in a single hepatocyte. The £uorescein
£uorescence trace was normalized to the £uorescence values ob-
tain after collapsing the PMF by addition of the uncoupler,
1799.
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NAD(P)H levels and energy metabolism than a sus-
tained elevation in [Ca2]c.
In preliminary studies, we have tested the e⁄cacy
of insulin, glucagon or K1-adrenergic agonists to
modulate the magnitude of vpHm in primary cul-
tured hepatocytes. Each of these hormones elevated
vpHm, however the rate of rise and extent of the
vpHm changes were signi¢cantly greater with Ca2-
mobilizing hormones (Robb-Gaspers and Thomas,
unpublished observation). While the exact mecha-
nism involved in stimulating mitochondrial PMF is
still under investigation, these initial observations
suggest the existence of both Ca2-dependent and
Ca2-independent pathways converging at the level
of the respiratory chain to regulate mitochondrial
function. In the intact liver, cross-talk between these
two pathways may be important in setting the ¢nal
metabolic output from the mitochondria.
6. Conclusions
The frequency of [Ca2]c spiking is determined by
the strength of the extracellular stimulus. Until re-
cently, little was known about how the cell decodes
these oscillatory [Ca2]c signals into a ¢nal metabolic
output. It can now be demonstrated that there is a
close coupling between IP3-dependent Ca2 release
from the ER and mitochondrial Ca2 uptake. The
preferential coupling between [Ca2]c and [Ca2]m
only occurs during the rising phase of the [Ca2]c
spike due to a localized, but short lived, high Ca2
domain that is sensed by the mitochondrial Ca2
uptake sites (Fig. 1). Thus, each large amplitude
[Ca2]c spike is e⁄ciently transferred into the mito-
chondrial matrix, whereas a sustained elevation in
[Ca2]c will only transiently increase [Ca2]m. So
far, two Ca2-sensitive intramitochondrial pathways
have been identi¢ed that are particularly adapted to
regulation by oscillatory [Ca2]c signals in a fre-
quency-dependent manner. These are mitochondrial
NAD(P)H production and the regulation of the mi-
tochondrial PMF. The rise in intramitochondrial
NAD(P)H levels is the result of increased £ux
through the Ca2-sensitive intramitochondrial dehy-
drogenases, while increased mitochondrial PMF may
occur through either a Ca2-dependent or Ca2-in-
dependent mechanism. The relatively slow decay of
mitochondrial NAD(P)H levels and PMF following
each [Ca2]m spike results in a sustain increase in
these parameters at higher [Ca2]m spiking frequen-
cies (= 0.5 spikes/min). As a consequence, Ca2-
sensitive intramitochondrial targets integrate the
oscillating cellular Ca2 signals into a smooth con-
tinuous metabolic output from the mitochondria.
These Ca2-mediated events would enhance the sup-
ply of respiratory substrates and increase the driving
force for mitochondrial ATP production, concomi-
tant with the activation of ATP utilizing pathways
in the cytosol. Furthermore, the mitochondria may
in turn modulate the cytosolic Ca2 signals, both
through the rapid phase of Ca2 uptake and because
the increase in v8m could enhance the rate of mito-
chondrial Ca2 sequestration.
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